These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8587801)

  • 61. Schistosoma mansoni: the effects of a subcurative dose of praziquantel on the ultrastructure of worms in vivo.
    Shaw MK; Erasmus DA
    Z Parasitenkd; 1983; 69(1):73-90. PubMed ID: 6340360
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro effect of curcumin on Schistosoma species viability, tegument ultrastructure and egg hatchability.
    Abou El Dahab MM; Shahat SM; Mahmoud SSM; Mahana NA
    Exp Parasitol; 2019 Apr; 199():1-8. PubMed ID: 30790572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of praziquantel and oxamniquine on a Saudi Arabian strain of Schistosoma mansoni in mice.
    Ghandour AM; Banaja AA; Shalaby IM
    J Helminthol; 1990 Mar; 64(1):62-4. PubMed ID: 2110944
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 65. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug resistance in schistosomiasis.
    Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
    Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
    [No Abstract]   [Full Text] [Related]  

  • 67. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.
    Chalmers IW; Fitzsimmons CM; Brown M; Pierrot C; Jones FM; Wawrzyniak JM; Fernandez-Fuentes N; Tukahebwa EM; Dunne DW; Khalife J; Hoffmann KF
    PLoS Negl Trop Dis; 2015; 9(7):e0003920. PubMed ID: 26147973
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Induction of immunity against Schistosoma mansoni by drug (Ro11-3128)-terminated infections: analysis of surface antigen recognition.
    Bickle QD; Sacko M; Vignali DA
    Parasite Immunol; 1990 Nov; 12(6):569-86. PubMed ID: 2128114
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of praziquantel treatment on lung-stage larvae of Schistosoma mansoni in vivo.
    Flisser A; McLaren DJ
    Parasitology; 1989 Apr; 98 Pt 2():203-11. PubMed ID: 2474788
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrastructural changes of adult Schistosoma mansoni worms recovered from C57BL/6 mice passively immunized with normal and vaccinated rabbit sera in vivo.
    Abdeen SH; Reda ES; El-Shabasy EA; Ouhtit A
    Parasitol Res; 2012 Jan; 110(1):37-47. PubMed ID: 21614547
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Schistosoma mansoni cationic egg antigens (CEF6): immunoserology with oxamniquine-treated patients and involvement of CEF6 in the circumoval precipitin reaction.
    Dunne DW; Hillyer GV; Vazquez G
    Am J Trop Med Hyg; 1988 May; 38(3):508-14. PubMed ID: 3152779
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lethal effect of oxamniquine and praziquantel on mice experimentally infected with Schistosoma mansoni.
    Tonelli SM; Goulart EM; Tonelli E; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1995; 37(4):361-3. PubMed ID: 8599068
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Schistosoma mansoni: evaluation of the activity of oxamniquine on schistosomules, at 24 hours after infection.
    Coelho PM; de Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):557-61. PubMed ID: 7997761
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of schistosomiasis: gathering stones together.
    Lambertucci JR
    Mem Inst Oswaldo Cruz; 1995; 90(2):161-4. PubMed ID: 8531651
    [No Abstract]   [Full Text] [Related]  

  • 75. Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection.
    Vimieiro AC; Araújo N; Katz N; Kusel JR; Coelho PM
    Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):881-6. PubMed ID: 24271044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
    Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
    Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Schistosoma mansoni: ultrastructure of adults from mice treated with oxamniquine.
    Popiel I; Erasmus DA
    Exp Parasitol; 1984 Dec; 58(3):254-62. PubMed ID: 6499999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynamics of serological responses to defined recombinant proteins during Schistosoma mansoni infection in mice before and after the treatment with praziquantel.
    Mohammed ES; Nakamura R; Kalenda YD; Deloer S; Moriyasu T; Tanaka M; Fujii Y; Kaneko S; Hirayama K; Ibrahim AI; El-Seify MA; Metwally AM; Hamano S
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008518. PubMed ID: 32915790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunological analysis of cloned Schistosoma mansoni antigens Sm31 and Sm32 with sera of schistosomiasis patients.
    Klinkert MQ; Bommert K; Moser D; Felleisen R; Link G; Doumbo O; Beck E
    Trop Med Parasitol; 1991 Dec; 42(4):319-24. PubMed ID: 1796225
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.